Cardiovascular & Hematological Disorders-Drug Targets

(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders)


Garry X. Shen
University of Manitoba
Winnipeg, MB


Become EABM
Become Reviewer

Evaluation and Management of Atrial Fibrillation

Volume:6   Issue: 4
Pp: 233-244
Sheharyar Ali, Mauricio Hong, Eduardo S. Antezano and Iqwal Mangat
DOI: 10.2174/187152906779010728

An Update on Clinical and Pharmacological Aspects of Drug-Eluting Stents

Volume:6   Issue: 4
Pp: 245-255
Rafik R. Anis, Karl R. Karsch and Martin Oberhoff
DOI: 10.2174/187152906779010755

Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector?

Volume:6   Issue: 4
Pp: 257-266
R. S. Carreira, P. Monteiro, L. M. Goncalves and L. A. Providencia
DOI: 10.2174/187152906779010746

Anti-Inflammatory Effects of Different Drugs/Agents with Antioxidant Property on Endothelial Expression of Adhesion Molecules

Volume:6   Issue: 4
Pp: 279-304
Yung-Hsiang Chen, Shing-Jong Lin, Yuh-Lien Chen, Po-Len Liu and Jaw-Wen Chen
DOI: 10.2174/187152906779010737